UBS Group’s Creative Medical Technology CELZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5 | Hold |
2
| – | – | ﹤0.01% | 8848 |
|
|
2025
Q1 | $4 | Buy |
2
+1
| +100% | +$2 | ﹤0.01% | 8828 |
|
|
2024
Q4 | $2 | Sell |
1
-2,724
| -100% | -$5.45K | ﹤0.01% | 8605 |
|
|
2024
Q3 | $8.45K | Buy |
+2,725
| New | +$8.45K | ﹤0.01% | 6629 |
|
|
2024
Q2 | – | Sell |
-3,064
| Closed | -$16K | – | 8374 |
|
|
2024
Q1 | $16K | Buy |
3,064
+2,022
| +194% | +$10.5K | ﹤0.01% | 5852 |
|
|
2023
Q4 | $4.8K | Sell |
1,042
-50
| -5% | -$231 | ﹤0.01% | 6615 |
|
|
2023
Q3 | $5.37K | Buy |
1,092
+1,072
| +5,360% | +$5.28K | ﹤0.01% | 6234 |
|
|
2023
Q2 | $93 | Buy |
+20
| New | +$93 | ﹤0.01% | 7436 |
|
|
2023
Q1 | – | Sell |
-3,090
| Closed | -$11.7K | – | 8514 |
|
|
2022
Q4 | $11.7K | Buy |
3,090
+2,012
| +187% | +$7.65K | ﹤0.01% | 7168 |
|
|
2022
Q3 | $5K | Buy |
+1,078
| New | +$5K | ﹤0.01% | 8066 |
|
|
2022
Q2 | – | Sell |
-916
| Closed | -$36K | – | 9286 |
|
|
2022
Q1 | $36K | Buy |
+916
| New | +$36K | ﹤0.01% | 5781 |
|